BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32060059)

  • 1. α
    Murphy MP; McEnery T; McQuillan K; McElvaney OF; McElvaney OJ; Landers S; Coleman O; Bussayajirapong A; Hawkins P; Henry M; Meleady P; Reeves EP; McElvaney NG
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32060059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
    Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Hawkins P; McEnery T; Gabillard-Lefort C; Bergin DA; Alfawaz B; Shutchaidat V; Meleady P; Henry M; Coleman O; Murphy M; McElvaney NG; Reeves EP
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34881324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
    McEnery T; White MM; Gogoi D; Coleman O; Bergin D; Jundi B; Flannery R; Alsaif FAT; Landers SA; Casey M; Dunlea D; Meleady P; McElvaney NG; Reeves EP
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):76-88. PubMed ID: 35507773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.
    Fee LT; Gogoi D; O'Brien ME; McHugh E; Casey M; Gough C; Murphy M; Hopkins AM; Carroll TP; McElvaney NG; Reeves EP
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α
    Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
    Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.
    Fraughen DD; Ghosh AJ; Hobbs BD; Funk GC; Meischl T; Clarenbach CF; Sievi NA; Schmid-Scherzer K; McElvaney OJ; Murphy MP; Roche AD; Clarke L; Strand M; Vafai-Tabrizi F; Kelly G; Gunaratnam C; Carroll TP; McElvaney NG
    Am J Respir Crit Care Med; 2023 Nov; 208(9):964-974. PubMed ID: 37624745
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
    Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
    J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
    Rahaghi FF; Monk R; Ramakrishnan V; Beiko T; Strange C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3193-3199. PubMed ID: 33299307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
    Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
    BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.
    Bergin DA; Reeves EP; Hurley K; Wolfe R; Jameel R; Fitzgerald S; McElvaney NG
    Sci Transl Med; 2014 Jan; 6(217):217ra1. PubMed ID: 24382893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
    Ataya A
    Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.